HYLEUKIN Canadian Trademark Information

On Thursday, March 21, 2019, a canadian trademark registration was filed for HYLEUKIN by Genexine, Inc. *********, **********, ***** ****. The Canadian IP office has given the trademark application number of 1952795. The current status of this trademark filing is Registration published. The HYLEUKIN trademark is filed in the description of Pharmaceutical preparations for wounds; Vaccines for human use; Pharmaceutical preparations for the treatment of cancer; Antibiotics; Antibiotic preparations; Pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; Cardiovascular pharmaceutical preparations; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparations for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; Blood substitutes; Pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; Pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; All purposes disinfectants; Fungicides; Medicated cold relief candy; Pharmaceutical preparations for the treatment of diabetes; Pharmaceutical preparations for treating respiratory diseases; Synthetic peptides for pharmaceutical purposes; Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; Pharmaceutical preparations for dwarfism; Intestinal disorder medicine for the treatment of ulcerative colitis; Medicines for the treatment of short-bowel syndrome; Medicines for the treatment of psoriasis; Pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; Pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; and Pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS) , Pharmaceutical preparations for wounds; Vaccines for human use; Pharmaceutical preparations for the treatment of cancer; Antibiotics; Antibiotic preparations; Pharmaceutical preparations for the treatment of inflammatory diseases, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; Cardiovascular pharmaceutical preparations; Pharmaceutical agents affecting sensory organs; Pharmaceutical preparations for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; Blood substitutes; Pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; Pharmaceutical preparations for the treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; All purposes disinfectants; Fungicides; Medicated cold relief candy; Pharmaceutical preparations for the treatment of diabetes; Pharmaceutical preparations for treating respiratory diseases; Synthetic peptides for pharmaceutical purposes; Pharmaceutical preparations for the treatment of blood disorders; Pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; Pharmaceutical preparations for dwarfism; Intestinal disorder medicine for the treatment of ulcerative colitis; Medicines for the treatment of short-bowel syndrome; Medicines for the treatment of psoriasis; Pharmaceutical preparations for the treatment of the musculoskeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; Pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; and Pharmaceutical preparations for the treatment of viral diseases, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS) .